+1 310-279-5152 (US)
+1 800-859-7036 (US)
+8 800-505-5785 (Russia)

  Call 1-800-859-7036 anytime to order or
discuss your options with our oncologists.

Scientific Research:

Scientific Research by Medolife

Medolife has conducted its own independent scientific research related to the effects of blue scorpion venom on cancer patients. This research also validates previous results achieved by Cuban researchers.

Escozine® users were categorized by type of cancer, stage of cancer and general health according to the Karnofsky scale. Results of these case studies were used to:

• Generate a protocol for Escozine® intake.
• Create a validation chart for potential effectiveness of Escozine® for each patient.
• Formulate a new potent mix of natural cancer fighting ingredients with blue scorpion serum.

General Observations

Not all people benefit equally from using Escozine®. The majority of Escozine® users receive noticeable results almost immediately and a small group of patients show little or no significant improvement.

Medolife has developed several criteria to systemize all possible elements which influence the effectiveness of Escozine® (to the best of our knowledge). We have empirically studied these factors to come to the following observations:

• Those cases for which Escozine® tends to have greater benefit.
• Those cases for which Escozine® tends to have the least benefit.
• Those cases for which benefits can be significant from longer use of Escozine®.
• Those cases for which additional complimentary therapies can be used to increase the effectiveness of Escozine®.

Please go to the Escozine® Success Calculator to find out the probability rate of your success.

Why Does Escozine® Benefit Some Cancer Patients More than Others?

Some factors influence the effectiveness of Escozine®.

Below is a list of these factors:

Factor 1: Stage of Cancer

In clinical trials, Escozine® exhibits an impressively high success rate for all stages of cancer. This effectiveness is moderated by multiple factors which are listed below:

Factor 2: Metastasis

Whether cancer is localized or has metastasized, Escozine® will increase the body's natural ability to fight cancer. However, greater benefit occurs when metastasis has not compromised the function of major vital organs.

Factor 3: Additional Complicating Health Conditions

Many patients with chronic degenerative conditions have shown improvement in their overall health after taking Escozine®. However, cancer patients who also have chronic health issues affecting the function of their vital organs (i.e. diabetes, cirrhosis, thyroid disease, etc.) generally have more complex medical issues.

For this reason, some cancer patients who also have chronic degenerative conditions that affect vital organ function do not respond as rapidly/profoundly as patients with simpler conditions. In these complex cases, additional factors take on a heightened degree of importance.

Factor 4: Ongoing Exposure to Environmental Toxins

The root cause of many cases of cancer is over-exposure to any of the various carcinogenic toxins found in our environments. If a person’s cancer is rooted in exposure to environmental toxins, it is very important for Escozine®’s efficacy that the person remove themselves from that high-toxicity environment. Otherwise, the root cause of their cancer will continue to be supported and the benefit of Escozine® will be limited.

Factor 5: Genetic Issues

Some cancer patients have a genetic (family) history of cancer. These genetically-influenced cancers are often triggered by certain environmental and biological factors. For these reasons, additional health and environmental factors become very important, as they may retrigger genetic pathways to cancer.

Escozine® supports the body’s natural mechanisms for fighting cancer and Escozine® has shown great promise as a preventative measure. However, with patients with a genetic predisposition towards developing cancer, Escozine® should be used as a complimentary therapy as a larger perspective is essential to produce the most positive results.

Factor 6: Psychological/Environmental Stress

Medolife has found that clients under significant amounts of psychological and/or environmental stress tend to have greater challenges with their recovery from cancer.

For example, theories suggest that stresses, such as depression, lead to excesses of hormones including adrenal corticosteroids. It is through these corticosteroids that immuno-suppression is controlled. Evidence for this in humans includes findings of increased levels of corticosteroids and immune system suppression in depressed patients as compared to non-depressed subjects. Patients with compromised immune systems have been shown to have higher rates of cancer

Medolife recommends that patients limit psychological and/or environmental stresses to get the most out of taking Escozine®.

Factor 7: Dietary/Nutritional Factors

Nutrition and diet play a key role in the development of many cancers. Nutritional deficiencies and dietary imbalances (excessive saturated fat, lack of fiber, excessive chemical additives, etc.) have been shown to influence the development of cancer. It is essential for the benefit of an Escozine® user that they maintain a healthy, balanced diet.

Escozine® users who continue to maintain an unhealthy, nutrient deficient diet do not benefit from Escozine® as well as those who maintain a health conscious approach to nutrition and diet.

Factor 8: Obesity

Many studies have shown a direct relationship between obesity and rates of cancer. Obesity may influence inflammatory responses in the body which may complicate the effectiveness of cancer-fighting therapies.

Medolife recommends that patients work to keep their weight at a healthy level when using Escozine®.

Factor 9: Sufficient Sleep

Scientific links have been discovered connecting cancer progression and insufficient sleep.

Most Escozine® users report improved sleep patterns after taking the product. However, it is important for patients to recognize the value of sufficient sleep in assisting in their recovery.

Factor 10: Psychological State/Commitment to Healing

Multiple studies have shown that individuals with an optimistic outlook towards their life and healing show better results than those who have a negative, pessimistic view towards life and the future. Though this is not always the case, as a general trend Medolife has seen that those who are fully committed to their healing tend to have more positive results than those who have given up hope.